{"success":true,"data":{"pressRelease":{"id":"163543","rtpr_id":"nGNXpg437-20261007","ticker":"CLOV","exchange":"NASDAQ","all_tickers":["CLOV"],"title":"Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026","author":"Globe Newswire","published_at":"2026-10-07T20:05:00.198Z","article_body":"WILMINGTON, Del., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments,\nCorp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”),\ntoday announced that it will release its financial results after the market\ncloses on Wednesday, November 4, 2026. The Company’s management will host a\nwebcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the\ncompany’s business and financial performance for the quarter.\n\nThird Quarter 2026 Conference Webcast Details:\n* What: Clover Health’s Third Quarter 2026 Earnings Conference Call\n* When: Wednesday, November 4, 2026, at 5:00 p.m. Eastern Time\n* Webcast: To access the webcast, you may register at\nhttps://clover-health-3q-2026-earnings.open-exchange.net/.\nA live and archived webcast of the conference call will also be accessible\nfrom the Investor Relations section of Clover Health’s website at\nhttps://investors.cloverhealth.com/ for 12 months.\n\nAbout Clover Health:\nClover Health (Nasdaq: CLOV) is a physician enablement technology company\ncommitted to bringing access to great healthcare to everyone on Medicare. This\nincludes a focus on seniors who have historically lacked access to affordable,\nhigh-quality healthcare. Our strategy is powered by our software platform,\nClover Assistant, which is designed to aggregate patient data from across the\nhealthcare ecosystem to support clinical decision-making and improve health\noutcomes through the early identification and management of chronic disease.\nFor our members, we provide PPO and HMO Medicare Advantage plans in several\nstates, with a differentiated focus on our flagship wide-network, high-choice\nPPO plans. For healthcare providers outside Clover Health's Medicare Advantage\nplan, we extend the benefits of our data-driven technology platform to a wider\naudience via our subsidiary, Counterpart Health, and aim to enable enhanced\npatient outcomes and reduced healthcare costs on a nationwide scale. Clover\nHealth has published data demonstrating the technology’s impact on\nMedication Adherence\n(https://www.globenewswire.com/Tracker?data=twBIZ-FQWlZrvj4Kv5tkGZcFC6oGIPydOLXlOa2vEvSTvw0_PazDeGt1Wy_RG0DYSrGW3s7XQ0gvHiEQGo9_3ZOqSToOYxtCYCXiupBvulnbDytrbsjUmPnP6qppkfAN43W--LUBKSb6JbaczS9G4MraUyaVNb0pBhaDz5LvQQCiSdk_UWvhQIrExb48jmjA-wYppoQpos7HBiOLq8L9BMizMK9nOSpTZu2lHdeBLreMCfEz0IbF4j1K1TI65-zY55NoWKUd86XG1JtKrBIRQMo99P0LTOM5NjrQURpxDBA=),\nCongestive Heart Failure\n(https://www.globenewswire.com/Tracker?data=y9d0z9WBgtNhSykge2V2ukCP5gTuGBxAv--WNHNnXpSUuBg2STUa9cdBmbWFew9c8xfFl3WzGky5dqk2tvxfmPC3jKl5O8m6LyquTxwXg_gI1F88lob2OdpiZt7I-U08PnI4TZ27zCdhddPmVNdKNr64pnmXSBRbpx6CkPhD-AnB2yAXIzJkZg4u2iaZEsFWbU9NirPrd4oyFsDHKA7LfwmyzYcaj6jKteYGX6SqTtEE2sOu95hBKHp0uIxigRqKlpOWdK_6YfKSYvTsyIsjFlHlVTLJqAuOMUB1mQ6pamnioDLHqNUolQvzgOBCl-9HXxObjLC9Bc6iTY4TSwfcXjbsl7ng-vWKrqG3w0XmQ4s=),\nChronic Obstructive Pulmonary Disease\n(https://www.globenewswire.com/Tracker?data=1ybSQI0AI08DIvEvgWzZ9xkaBU4R7XEzIT0B5hBtNidn6kwtA1NZ_iQicpCwB5_-bwHBzDQZI6POUmIfLjFfEapz_9B6Sj_5OsQUnR9oHHJPNUrXYy5BjyCd3xHitoGDMA1EKOM9YjOYW0HeURGH4YT4ibdYmpi5c0Sm3UBNix0hAkezPmYrq6d2MHlFfGZm),\nand in Underserved Populations\n(https://www.globenewswire.com/Tracker?data=BbUQy2KDdAfg72hM3Azvb13ov2FzRYRzggUPuXZavcU55mJMKIg7x9wJzoTKjuIYLh3LVmHabsZJ29x-qLGrXtqUAtoxhDsILNLpeWj--rl8hh0ReiPKDtyCGM9blCzeqY_HH0TtgmD7JYUywn9XoPDGpk7ftZP4ihelDdgVB9C36RpBmnO1gTHqBxsTEVnMpnZuWuzll42pAY3REXR06FwgEkep8ejzz4M159J2TvXqAJby_3hJDtSuD1UGylbFz-6l8k6AvU4yGjOeaLs-nksceu25XjtrYIGbhoaaGhLo5SkM9HYTu97ViMuZ6eT2DDaiaI5AFoz-HGoxjW-pShS99xrlPCkKDr1P24BKBgbDkDFieAkCAlysIDZK9FJMbA7nqQa_E6qWln17OohTSQq_g_9SMQ7O8Gg96Zrb6xoHUMbizX8Syd7UmZZ8vARyH16Z7w3zvDP8KCx86qT1wqYAFRN0S_PeUAyJv3XGgzjh4rdNY5s_geMNIkIB-BMrcbbwnVlyTj5Un6clbZk2Cw==)\nas well as the earlier identification and management of Diabetes\n(https://www.globenewswire.com/Tracker?data=_pq_jd1PeBSAEpFJhmJYWYPw8EqbRx94TzZmfWLSpt5_ikF9dO53MZBYKbZIYsG13uNSQghOvhJMXjYoCke55KCkQqHwiewNkpOwJ70o4kj9ZCNJQCUwHmg_xP_aDReaQZtFaF5eyNcTN_wkNlK9kNPD9qJAIfeQSL5m4V0iau-uzFFnaQFvuRkrExECgZO8E-M4GeN3YkmK1f-Tq8RKelC6rWvryWO8TfQLEaJh9Efa81er7GGwXnXkM3Af8SCRrHl9Cq8N52EaxRpQADCLsA==)\nand Chronic Kidney Disease\n(https://www.globenewswire.com/Tracker?data=1ybSQI0AI08DIvEvgWzZ9_UOA3-2d2x0pRZBO64TaAL211GeZf-RJBhVkqZSD2-0bcdVreluTInvIOz1u1dPADTNQ1qh2kdBFYWBYRlywZe3lwDERLGLBBNOE7Woo6nEdHEEd2OyAksGacIMS04zeKCXaNwkO0SytHZG9Jzn6PmdqGc3QdGAHzxDeBSoQXfpTG5GfoQZvddW4rFozRELKzX7XhWbNZeFmndlZ7hM--k=).\n\nInvestor Relations:\nRyan Schmidt\ninvestors@cloverhealth.com\n\nPress Inquiries:\npress@cloverhealth.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/1a48a25b-b654-4d62-adb3-d1a776346264)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNXpg437-20261007","title":"Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026","author":"Globe Newswire","ticker":"CLOV","created":"2026-10-07T20:05:00.198Z","tickers":["CLOV"],"exchange":"NASDAQ","article_body":"WILMINGTON, Del., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments,\nCorp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”),\ntoday announced that it will release its financial results after the market\ncloses on Wednesday, November 4, 2026. The Company’s management will host a\nwebcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the\ncompany’s business and financial performance for the quarter.\n\nThird Quarter 2026 Conference Webcast Details:\n* What: Clover Health’s Third Quarter 2026 Earnings Conference Call\n* When: Wednesday, November 4, 2026, at 5:00 p.m. Eastern Time\n* Webcast: To access the webcast, you may register at\nhttps://clover-health-3q-2026-earnings.open-exchange.net/.\nA live and archived webcast of the conference call will also be accessible\nfrom the Investor Relations section of Clover Health’s website at\nhttps://investors.cloverhealth.com/ for 12 months.\n\nAbout Clover Health:\nClover Health (Nasdaq: CLOV) is a physician enablement technology company\ncommitted to bringing access to great healthcare to everyone on Medicare. This\nincludes a focus on seniors who have historically lacked access to affordable,\nhigh-quality healthcare. Our strategy is powered by our software platform,\nClover Assistant, which is designed to aggregate patient data from across the\nhealthcare ecosystem to support clinical decision-making and improve health\noutcomes through the early identification and management of chronic disease.\nFor our members, we provide PPO and HMO Medicare Advantage plans in several\nstates, with a differentiated focus on our flagship wide-network, high-choice\nPPO plans. For healthcare providers outside Clover Health's Medicare Advantage\nplan, we extend the benefits of our data-driven technology platform to a wider\naudience via our subsidiary, Counterpart Health, and aim to enable enhanced\npatient outcomes and reduced healthcare costs on a nationwide scale. Clover\nHealth has published data demonstrating the technology’s impact on\nMedication Adherence\n(https://www.globenewswire.com/Tracker?data=twBIZ-FQWlZrvj4Kv5tkGZcFC6oGIPydOLXlOa2vEvSTvw0_PazDeGt1Wy_RG0DYSrGW3s7XQ0gvHiEQGo9_3ZOqSToOYxtCYCXiupBvulnbDytrbsjUmPnP6qppkfAN43W--LUBKSb6JbaczS9G4MraUyaVNb0pBhaDz5LvQQCiSdk_UWvhQIrExb48jmjA-wYppoQpos7HBiOLq8L9BMizMK9nOSpTZu2lHdeBLreMCfEz0IbF4j1K1TI65-zY55NoWKUd86XG1JtKrBIRQMo99P0LTOM5NjrQURpxDBA=),\nCongestive Heart Failure\n(https://www.globenewswire.com/Tracker?data=y9d0z9WBgtNhSykge2V2ukCP5gTuGBxAv--WNHNnXpSUuBg2STUa9cdBmbWFew9c8xfFl3WzGky5dqk2tvxfmPC3jKl5O8m6LyquTxwXg_gI1F88lob2OdpiZt7I-U08PnI4TZ27zCdhddPmVNdKNr64pnmXSBRbpx6CkPhD-AnB2yAXIzJkZg4u2iaZEsFWbU9NirPrd4oyFsDHKA7LfwmyzYcaj6jKteYGX6SqTtEE2sOu95hBKHp0uIxigRqKlpOWdK_6YfKSYvTsyIsjFlHlVTLJqAuOMUB1mQ6pamnioDLHqNUolQvzgOBCl-9HXxObjLC9Bc6iTY4TSwfcXjbsl7ng-vWKrqG3w0XmQ4s=),\nChronic Obstructive Pulmonary Disease\n(https://www.globenewswire.com/Tracker?data=1ybSQI0AI08DIvEvgWzZ9xkaBU4R7XEzIT0B5hBtNidn6kwtA1NZ_iQicpCwB5_-bwHBzDQZI6POUmIfLjFfEapz_9B6Sj_5OsQUnR9oHHJPNUrXYy5BjyCd3xHitoGDMA1EKOM9YjOYW0HeURGH4YT4ibdYmpi5c0Sm3UBNix0hAkezPmYrq6d2MHlFfGZm),\nand in Underserved Populations\n(https://www.globenewswire.com/Tracker?data=BbUQy2KDdAfg72hM3Azvb13ov2FzRYRzggUPuXZavcU55mJMKIg7x9wJzoTKjuIYLh3LVmHabsZJ29x-qLGrXtqUAtoxhDsILNLpeWj--rl8hh0ReiPKDtyCGM9blCzeqY_HH0TtgmD7JYUywn9XoPDGpk7ftZP4ihelDdgVB9C36RpBmnO1gTHqBxsTEVnMpnZuWuzll42pAY3REXR06FwgEkep8ejzz4M159J2TvXqAJby_3hJDtSuD1UGylbFz-6l8k6AvU4yGjOeaLs-nksceu25XjtrYIGbhoaaGhLo5SkM9HYTu97ViMuZ6eT2DDaiaI5AFoz-HGoxjW-pShS99xrlPCkKDr1P24BKBgbDkDFieAkCAlysIDZK9FJMbA7nqQa_E6qWln17OohTSQq_g_9SMQ7O8Gg96Zrb6xoHUMbizX8Syd7UmZZ8vARyH16Z7w3zvDP8KCx86qT1wqYAFRN0S_PeUAyJv3XGgzjh4rdNY5s_geMNIkIB-BMrcbbwnVlyTj5Un6clbZk2Cw==)\nas well as the earlier identification and management of Diabetes\n(https://www.globenewswire.com/Tracker?data=_pq_jd1PeBSAEpFJhmJYWYPw8EqbRx94TzZmfWLSpt5_ikF9dO53MZBYKbZIYsG13uNSQghOvhJMXjYoCke55KCkQqHwiewNkpOwJ70o4kj9ZCNJQCUwHmg_xP_aDReaQZtFaF5eyNcTN_wkNlK9kNPD9qJAIfeQSL5m4V0iau-uzFFnaQFvuRkrExECgZO8E-M4GeN3YkmK1f-Tq8RKelC6rWvryWO8TfQLEaJh9Efa81er7GGwXnXkM3Af8SCRrHl9Cq8N52EaxRpQADCLsA==)\nand Chronic Kidney Disease\n(https://www.globenewswire.com/Tracker?data=1ybSQI0AI08DIvEvgWzZ9_UOA3-2d2x0pRZBO64TaAL211GeZf-RJBhVkqZSD2-0bcdVreluTInvIOz1u1dPADTNQ1qh2kdBFYWBYRlywZe3lwDERLGLBBNOE7Woo6nEdHEEd2OyAksGacIMS04zeKCXaNwkO0SytHZG9Jzn6PmdqGc3QdGAHzxDeBSoQXfpTG5GfoQZvddW4rFozRELKzX7XhWbNZeFmndlZ7hM--k=).\n\nInvestor Relations:\nRyan Schmidt\ninvestors@cloverhealth.com\n\nPress Inquiries:\npress@cloverhealth.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/1a48a25b-b654-4d62-adb3-d1a776346264)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-10-07T20:05:00.256490975Z","server_sent_at_ms":1791403500256},"received_at":"2026-10-07T20:05:00.464Z","source_url":null},"analysis":{"id":"151990","press_release_id":"163543","analysis_json":{"industry":{"label":"Health Care Providers & Services","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Clover Health announced it will release third quarter 2026 financial results after the market close on Wednesday, November 4, 2026.\n\nManagement will host a webcast at 5:00 p.m. Eastern Time that day, with a live and archived stream available for 12 months on the investor relations site.\n\nThe notice contains no financial figures; treat as a calendar item ahead of the Q3 print.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Calendar note: CLOV Q3 2026 results due November 4 after the close."},"keyFigures":{},"namedEntities":{"people":[{"name":"Ryan Schmidt","role":"Investor Relations"}],"products":["Clover Assistant","Counterpart Health"],"companies":[{"name":"Clover Health Investments, Corp.","ticker":"CLOV"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"This is a routine earnings-date announcement with no results, guidance, or other material information. Per the rubric, scheduling notices score 1."},"tickerRelevance":{"others":[],"primary":"CLOV"},"globalImportance":10,"audienceRelevance":25,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap-retail-favorite","eventGravity":"earnings-date-notice","issuerAuthored":true}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Clover Health announced it will release third quarter 2026 financial results after the market close on Wednesday, November 4, 2026.\n\nManagement will host a webcast at 5:00 p.m. Eastern Time that day, with a live and archived stream available for 12 months on the investor relations site.\n\nThe notice contains no financial figures; treat as a calendar item ahead of the Q3 print.","key_figures":{},"named_entities":{"people":[{"name":"Ryan Schmidt","role":"Investor Relations"}],"products":["Clover Assistant","Counterpart Health"],"companies":[{"name":"Clover Health Investments, Corp.","ticker":"CLOV"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-07T20:05:03.936Z","global_importance":10,"audience_relevance":25,"importance_components":{"tickerTier":"small-cap-retail-favorite","eventGravity":"earnings-date-notice","issuerAuthored":true}},"durationMs":3453,"modelName":"glm-5.3-flashx"}}